Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CNS-selective effects of synthetic, nonfeminizing estrogens

July 7, 1998

New antimigraine option now available in Canada

July 7, 1998

Ganaxolone study results presented at AASH meeting

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

July 7, 1998

S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats

July 6, 1998

CNI-1493 treatment associated with improvement in mouse model of MS

July 6, 1998

Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia

July 6, 1998

Berlex and Chiron file with FDA to treat progressive form of MS

July 6, 1998

Analgesics prepared at Ostuka

July 3, 1998

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...